Highlights,Geron Corporation's focus on treatments for myelodysplastic syndromes gains attention.,Recent European Medicines ...

We recently compiled a list of the 10 Best Penny Stocks to Buy for 2025. In this article, we are going to take a look at ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Imetelstat sodium is under clinical development by Geron and currently in Phase I for Juvenile Myelomonocytic Leukemia (JMML).

Geron Corporation (NASDAQ:GERN) has a negative Return on Invested Capital (ROIC) of -68.21%, indicating challenges in ...

Geron Co. (NASDAQ:GERN – Get Free Report) has been given a consensus recommendation of “Buy” by the eleven analysts that are ...

On Tuesday, Geron Corp (GERN) stock saw a modest uptick, ending the day at $3.34 which represents no change from the prior close of of $3.34. The stock opened at $3.34 and touched a low of $3.28 ...

Seeking Alpha's Quant system consistently outperforms the S&P 500 ( SP500 ), driven by powerful computer processing and SA's ...

Geron Corp (GERN) stock saw a decline, ending the day at $3.49 which represents a decrease of $-0.17 or -4.64% from the prior close of $3.66. The stock opened at $3.61 and touched a low of $3.46 ...

Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an ...